Pentobarbital coma therapy for super-refractory status epilepticus and in-hospital mortality: an observational study.

MLA

Koh, Seungyon, et al. “Pentobarbital Coma Therapy for Super-Refractory Status Epilepticus and in-Hospital Mortality: An Observational Study.” Epileptic Disorders : International Epilepsy Journal with Videotape, vol. 23, no. 6, Dec. 2021, pp. 833–42. EBSCOhost, https://doi.org/10.1684/epd.2021.1333.

APA

Koh, S., Kim, T.-J., Lim, T.-S., Lee, J. S., Kim, B. G., Park, S. A., Huh, K., & Choi, J. Y. (2021). Pentobarbital coma therapy for super-refractory status epilepticus and in-hospital mortality: an observational study. Epileptic Disorders : International Epilepsy Journal with Videotape, 23(6), 833–842. https://doi.org/10.1684/epd.2021.1333

Chicago

Koh, Seungyon, Tae-Joon Kim, Tae-Sung Lim, Jin Soo Lee, Byung Gon Kim, Sun Ah Park, Kyoon Huh, and Jun Young Choi. 2021. “Pentobarbital Coma Therapy for Super-Refractory Status Epilepticus and in-Hospital Mortality: An Observational Study.” Epileptic Disorders : International Epilepsy Journal with Videotape 23 (6): 833–42. doi:10.1684/epd.2021.1333.